- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | - | - |
| R2 | - | - |
| R3 | - | - |
| PP | - | - |
| S1 | - | - |
| S2 | - | - |
| S3 | - | - |
Ratios
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE | 19.05 | - | 5.9 | - | -4.32 |
| ROE | 16.75 | - | 4.59 | - | -4.4 |
| EPS | 0.45 | 1.08 | 0.77 | -0.21 | 0.21 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|---|---|---|---|---|
| No data available | |||||
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Kabra Drugs Ltd
Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M....
ISIN :INE323K01017
Registrars
Ankit Consultancy Pvt Ltd
Plot No. 60 Electronic Complex Pardeshipura Indore - 452010
Plot No. 60 Electronic Complex Pardeshipura Indore - 452010
Contact number
+ 91-0731-3198601/3198
Management
- (Chairman)
Open IPO’s
Price Range
₹182 - ₹192
Min. Quantity
78 Shares
Min. investment
₹14,976
Closes on
June 5, 2026
FAQs
The share price of Kabra Drugs Ltd on the BSE is - as on -